-
1
-
-
0034693398
-
Improved bioavailability to the brain of glycosylated Met Enkephalin analogs
-
R.D. Egleton, S.A. Mitchell, J.D. Huber, J. Janders, D. Stropova, D. Polt, H.I. Yamamura, V.J. Hruby, and T.P. Davis Improved bioavailability to the brain of glycosylated Met Enkephalin analogs Brain Res. 881 2000 37 46
-
(2000)
Brain Res.
, vol.881
, pp. 37-46
-
-
Egleton, R.D.1
Mitchell, S.A.2
Huber, J.D.3
Janders, J.4
Stropova, D.5
Polt, D.6
Yamamura, H.I.7
Hruby, V.J.8
Davis, T.P.9
-
2
-
-
0032759292
-
The effect of halogenation on blood-brain barrier permeability of a novel peptide drug
-
C.L. Gentry, R.D. Egleton, T. Gillespie, T.J. Abbruscato, H.B. Bechowski, V.J. Hruby, and T.P. Davis The effect of halogenation on blood-brain barrier permeability of a novel peptide drug Peptides 20 1999 1229 1238
-
(1999)
Peptides
, vol.20
, pp. 1229-1238
-
-
Gentry, C.L.1
Egleton, R.D.2
Gillespie, T.3
Abbruscato, T.J.4
Bechowski, H.B.5
Hruby, V.J.6
Davis, T.P.7
-
3
-
-
0032776598
-
Extended blood half-life of monomethoxypolyethylene glycol-conjugated hen lysozyme is a key parameter controlling immunological tolerogenicity
-
T. So, H.O. Ito, M. Hirata, T. Ueda, and T. Imoto Extended blood half-life of monomethoxypolyethylene glycol-conjugated hen lysozyme is a key parameter controlling immunological tolerogenicity Cell. Mol. Life Sci. 55 1999 1187 1194
-
(1999)
Cell. Mol. Life Sci.
, vol.55
, pp. 1187-1194
-
-
So, T.1
Ito, H.O.2
Hirata, M.3
Ueda, T.4
Imoto, T.5
-
4
-
-
0034682480
-
Site-specific chemical modification with polyethylene glycol of recombinant immunotoxin anti-Tac(Fv)-PE38 (LMB-2) improves antitumor activity and reduces animal toxicity and immunogenicity
-
Y. Tsutsumi, M. Onda, S. Nagata, B. Lee, R.J. Kreitman, and I. Pastan Site-specific chemical modification with polyethylene glycol of recombinant immunotoxin anti-Tac(Fv)-PE38 (LMB-2) improves antitumor activity and reduces animal toxicity and immunogenicity Proc. Natl. Acad. Sci. U. S. A. 97 2000 8548 8553
-
(2000)
Proc. Natl. Acad. Sci. U. S. A.
, vol.97
, pp. 8548-8553
-
-
Tsutsumi, Y.1
Onda, M.2
Nagata, S.3
Lee, B.4
Kreitman, R.J.5
Pastan, I.6
-
5
-
-
0026757191
-
Drug-polymer conjugates: Potential for improved chemotherapy
-
R. Duccan Drug-polymer conjugates: potential for improved chemotherapy Anti-Cancer Drugs 3 1992 175 210
-
(1992)
Anti-Cancer Drugs
, vol.3
, pp. 175-210
-
-
Duccan, R.1
-
6
-
-
0033525014
-
Bioconjugation of laminin peptide YIGSR with poly (stysene co-maleic acid) increases its metastatic effect on lung metastasis of B16-BL6 melanoma cells
-
Y. Mu, H. Kamada, Y. Kaneda, Y. Yamamoto, H. Koidara, S. Tsunoda, Y. Tsutsumi, M. Maeda, K. Kawasaki, M. Nomizu, Y. Yamada, and T. Mayumi Bioconjugation of laminin peptide YIGSR with poly (stysene co-maleic acid) increases its metastatic effect on lung metastasis of B16-BL6 melanoma cells Biochem. Biophys. Res. Commun. 255 1999 75 79
-
(1999)
Biochem. Biophys. Res. Commun.
, vol.255
, pp. 75-79
-
-
Mu, Y.1
Kamada, H.2
Kaneda, Y.3
Yamamoto, Y.4
Koidara, H.5
Tsunoda, S.6
Tsutsumi, Y.7
Maeda, M.8
Kawasaki, K.9
Nomizu, M.10
Yamada, Y.11
Mayumi, T.12
-
7
-
-
0018405532
-
Pharmacological effects of phosphatidylserine liposomes: Regulation of gylcolysis and energy level in brain
-
E. Bigon, E. Boarato, A. Bruni, A. Leon, and G. Toffano Pharmacological effects of phosphatidylserine liposomes: regulation of gylcolysis and energy level in brain Br. J. Pharmacol. 66 1979 167 174
-
(1979)
Br. J. Pharmacol.
, vol.66
, pp. 167-174
-
-
Bigon, E.1
Boarato, E.2
Bruni, A.3
Leon, A.4
Toffano, G.5
-
8
-
-
0037466349
-
Poly(alkylcyanoacrylates) as biodegradable materials for biomedical applications
-
C. Vauthier, C. Dubernet, E. Fattal, H. Pinto-Alphandry, and P. Couvreur Poly(alkylcyanoacrylates) as biodegradable materials for biomedical applications Adv. Drug Deliv. Rev. 55 2003 519 548
-
(2003)
Adv. Drug Deliv. Rev.
, vol.55
, pp. 519-548
-
-
Vauthier, C.1
Dubernet, C.2
Fattal, E.3
Pinto-Alphandry, H.4
Couvreur, P.5
-
9
-
-
0036388590
-
Nanocapsule technology: A review
-
P. Couvreur, G. Barratt, E. Fattal, P. Legrand, and C. Vauthier Nanocapsule technology: a review Crit. Rev. Drug Deliv. Syst. 19 2002 99 134
-
(2002)
Crit. Rev. Drug Deliv. Syst.
, vol.19
, pp. 99-134
-
-
Couvreur, P.1
Barratt, G.2
Fattal, E.3
Legrand, P.4
Vauthier, C.5
-
11
-
-
0004205412
-
-
2nd edn. Marcel Dekker New York
-
G. Barratt, G. Couarraze, P. Couvreur, C. Dubernet, E. Fattal, R. Gref, D. Labarre, P. Legrand, G. Ponchel, and C. Vauthier Polymeric Biomaterials 2nd edn. 2001 Marcel Dekker New York 753 782
-
(2001)
Polymeric Biomaterials
, pp. 753-782
-
-
Barratt, G.1
Couarraze, G.2
Couvreur, P.3
Dubernet, C.4
Fattal, E.5
Gref, R.6
Labarre, D.7
Legrand, P.8
Ponchel, G.9
Vauthier, C.10
-
12
-
-
5444259964
-
Water-soluble complexes from random copolymer and oppositely charged surfactant: 2. Complexes of poly(ethylene glycol)-based cationic random copolymer and bile salts
-
C.K. Nisha, V.S. Manorama, J.N. Kizhakkedathu, and S. Maiti Water-soluble complexes from random copolymer and oppositely charged surfactant: 2. Complexes of poly(ethylene glycol)-based cationic random copolymer and bile salts Langmuir 20 2004 8468 8475
-
(2004)
Langmuir
, vol.20
, pp. 8468-8475
-
-
Nisha, C.K.1
Manorama, V.S.2
Kizhakkedathu, J.N.3
Maiti, S.4
-
14
-
-
0038669001
-
Buccal delivery of acyclovir from films based on chitosan and polyacrylic acid
-
S. Rossi, G. Sandri, F. Ferrari, M.C. Bonferoni, and C. Caramella Buccal delivery of acyclovir from films based on chitosan and polyacrylic acid Pharm. Dev. Technol. 8 2003 199 208
-
(2003)
Pharm. Dev. Technol.
, vol.8
, pp. 199-208
-
-
Rossi, S.1
Sandri, G.2
Ferrari, F.3
Bonferoni, M.C.4
Caramella, C.5
-
15
-
-
0034464675
-
Insoluble ionic complexes of polyacrylic acid with a cationic drug for use as a mucoadhesive, ophthalmic drug delivery system
-
B.S. Lele, and A.S. Hoffman Insoluble ionic complexes of polyacrylic acid with a cationic drug for use as a mucoadhesive, ophthalmic drug delivery system J. Biomater. Sci., Polym. Ed. 11 2000 1319 1331
-
(2000)
J. Biomater. Sci., Polym. Ed.
, vol.11
, pp. 1319-1331
-
-
Lele, B.S.1
Hoffman, A.S.2
-
16
-
-
0032888076
-
Chimeric peptide of Met-enkephalin and FMRFa induces antinociception and attenuates development of tolerance to morphine antinociception
-
S. Gupta, S. Pasha, Y.K. Gupta, and D.K. Bhardwaj Chimeric peptide of Met-enkephalin and FMRFa induces antinociception and attenuates development of tolerance to morphine antinociception Peptides 20 1999 471 478
-
(1999)
Peptides
, vol.20
, pp. 471-478
-
-
Gupta, S.1
Pasha, S.2
Gupta, Y.K.3
Bhardwaj, D.K.4
|